Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (19)

2024

  1. Impact of prior use of antiplatelets on COVID-19 susceptibility, progression, and severity: a population-based study

    Revista Espanola de Cardiologia, Vol. 77, Núm. 7, pp. 539-546

2023

  1. A longitudinal and multidesign epidemiological study to analyze the effect of the volcanic eruption of Tajogaite volcano (La Palma, Canary Islands). The ASHES study protocol

    Environmental Research, Vol. 216

  2. Colchicine and risk of hospitalization due to COVID-19: A population-based study

    Journal of Medical Virology, Vol. 95, Núm. 2

  3. Differences in weight loss and safety between the glucagon-like peptide-1 receptor agonists: A non-randomized multicenter study from the titration phase

    Primary Care Diabetes, Vol. 17, Núm. 4, pp. 366-372

  4. Effect of Previous Anticoagulant Treatment on Risk of COVID-19

    Drug Safety, Vol. 46, Núm. 3, pp. 273-281

  5. Effect of dapagliflozin on COVID-19 infection and risk of hospitalization

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 9, pp. 2335-2342

  6. Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis

    Journal of cardiovascular pharmacology, Vol. 81, Núm. 1, pp. 70-75

  7. RE: Colchicine and risk of hospitalization due to COVID-19: A population-based study

    Journal of Medical Virology

  8. Validation of a small-area model for estimation of smoking prevalence at a subnational level

    Tobacco Induced Diseases, Vol. 21

2022

  1. Semaglutide versus GLP-1 agonists. Effectiveness, safety, and quality of life in patients with diabetes mellitus 2. The SEVERAL study

    Farmacia Hospitalaria, Vol. 46, Núm. 6, pp. 372-379

2021

  1. Presence of SEPAR members on the editorial committees of journals indexed in the “Respiratory System” category of Journal Citation Reports

    Archivos de Bronconeumologia

  2. Salivary dna methylation as an epigenetic biomarker for head and neck cancer. Part i: A diagnostic accuracy meta-analysis

    Journal of Personalized Medicine, Vol. 11, Núm. 6

  3. Salivary dna methylation as an epigenetic biomarker for head and neck cancer. Part ii: A cancer risk meta-analysis

    Journal of Personalized Medicine, Vol. 11, Núm. 7

  4. Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect

    American journal of respiratory and critical care medicine

2020

  1. Association of salivary human papillomavirus infection and oral and oropharyngeal cancer: A meta-analysis

    Journal of Clinical Medicine, Vol. 9, Núm. 5

  2. Reasons for medication non-initiation: A qualitative exploration of the patients’ perspective

    Research in Social and Administrative Pharmacy, Vol. 16, Núm. 5, pp. 663-672

  3. Response to commentary by Lu and Wang on “Salivary biomarkers for cancer diagnosis: a meta-analysis”

    Annals of Medicine

  4. Salivary biomarkers for cancer diagnosis: a meta-analysis

    Annals of Medicine, Vol. 52, Núm. 3-4, pp. 131-144

2009

  1. Fundamentos y aplicaciones del diseño de casos cruzados

    Gaceta Sanitaria, Vol. 23, Núm. 2, pp. 161-165